STOCK FOCUS OF THE DAY
Luxchem Corp : Mulling further capacity expansion BUY
We reiterate our BUY recommendation on Luxchem Corporation (Luxchem) with an unchanged fair value of RM0.91/share, based on 15x FY18F FD EPS. We have trimmed our FY17F earnings 18% following a disappointment in the 9MFY17 results. However, positive prospects of the company remain intact.
Luxchem recorded a net profit of RM9mil in 3QFY17, representing a slight QoQ improvement of 4%, but a decline of 10% YoY. For the cumulative period (9MFY17), the group's net profit inched up 4% YoY on the back of an 18% YoY expansion in revenue. The 9MFY17 came in below both our expectations and consensus at 63% and 66% of FY17F's full-year forecasts.
The results’ disappointment stemmed from a lower-than-expected improvement in 3QFY17's pre-tax margin, which increased 0.8ppt from 5.8% in 2QFY17 to 6.5% in 3QFY17. We had earlier expected improvements of a bigger quantum due to a recovery in chemical prices, including those of butadiene and unsaturated polyester resins (UPR). However, management said that the increase in the public reference price of chemical products was not well received by the market.
On a positive note, we gather that the revenue synergies from its newly acquired Transform Master (TMSB) were fruitfully unlocked, evidenced by a quick capacity fill-up from 80% utilisation in 1HFY17 to full capacity currently. In light of this, management has indicated that the group is considering expanding TMSB's capacity further within the next two years (on top of the 2.4kt/year that is coming onstream by year-end). We view this positively as TMSB's products are largely sold to glove companies, which are experiencing sturdy growth.
QUICK TAKE
Top Glove : To buy Adventa’s operations ? HOLD
ECONOMIC HIGHLIGHT
Malaysia : Economy to continue growing positively in near term
NEWS HIGHLIGHTS
Sunway : To take full control of project by buying out EPF’s stake
Edaran: Bags RM149.97m information system upgrade job from customs
Tropicana: Top Glove’s Lim buys 10.24% stake
Pantech : Q2 net profit more than doubles
DISCLAIMER:
The information and opinions in this report were prepared by AmInvestment Bank Bhd. The investments discussed or recommended in this report may not be suitable for all investors. This report has been prepared for information purposes only and is not an offer to sell or a solicitation to buy any securities. The directors and employees of AmInvestment Bank Bhd. Bhd may from time to time have a position in or with the securities mentioned herein. Members of the AmBank Group Bhd and their affiliates may provide services to any company and affiliates of such companies whose securities are mentioned herein. The information herein was obtained or derived from sources that we believe are reliable, but while all reasonable care has been taken to ensure that stated facts are accurate and opinions fair and reasonable, we do not represent that it is accurate or complete and it should not be relied upon as such. No liability can be accepted for any loss that may arise from the use of this report. All opinions and estimates included in this report constitute our judgment as of this date and are subject to change without notice.
****************************************************************************************************************************************************************************************************************************************************************************************************************
DISCLAIMER:
This message may contain confidential and privileged information for its intended recipient(s) only. If you are not an intended recipient, you are hereby notified that any review, dissemination, and distribution, printing or copying of this message or any part thereof is strictly prohibited. Please delete the entire message and inform the sender of the error. Any opinions, conclusions and other information in this message that are unrelated to official business of AmBank Group are those of the individual sender and shall be understood as neither explicitly given nor endorsed by AmBank Group.
****************************************************************************************************************************************************************************************************************************************************************************************************************
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.